Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanns-Martin Lorenz

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|May 22, 2002
Abetimus (La Jolla pharmaceuticals)Hanns-Martin Lorenz
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 6, 2003
T-cell-activation inhibitors in rheumatoid arthritisHanns-Martin Lorenz
Current Rheumatology Reports|March 11, 2019
Idiopathic Pericarditis-an Autoinflammatory Disease?Norbert Blank, Hanns-Martin Lorenz
Innere Medizin (Heidelberg, Germany)|July 26, 2023
[Drug therapy of rheumatoid arthritis: where do biologics and novel synthetic disease-modifying antirheumatic drugs stand today?]Dorothee Kaudewitz, Hanns-Martin Lorenz
Arthritis Research|July 12, 2002
Perspectives for TNF-alpha-targeting therapiesHanns-Martin Lorenz, Joachim R Kalden
Deutsche Medizinische Wochenschrift (1946)|July 13, 2021
[Ocular manifestations of Rheumatic diseases]Janine Günther, Regina Max, Hanns-Martin Lorenz
Zeitschrift Fur Rheumatologie|September 1, 2021
[Chronic inflammatory demyelinating polyneuropathy as differential diagnosis to polymyalgia rheumatica]Martin Schiller, Hanns-Martin Lorenz, Wolfgang Kick
Arthritis Research & Therapy|September 16, 2016
Rituximab induces phenotypical and functional changes of NK cells in a non-malignant experimental settingWolfgang Merkt, Hanns-Martin Lorenz, Carsten Watzl
Biochemical Pharmacology|October 14, 2003
The putative role of apoptosis-modified histones for the induction of autoimmunity in Systemic Lupus ErythematosusChristoph Gabler, Joachim R Kalden, Hanns-Martin Lorenz
European Journal of Rheumatology|December 4, 2018
IL1-blocking therapy in colchicine-resistant familial Mediterranean feverBirgit Maria Köhler, Hanns-Martin Lorenz, Norbert Blank
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
Current Opinion in Investigational Drugs (London, England : 2000)|May 22, 2002
Abetimus (La Jolla pharmaceuticals)Hanns-Martin Lorenz
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 6, 2003
T-cell-activation inhibitors in rheumatoid arthritisHanns-Martin Lorenz
Current Rheumatology Reports|March 11, 2019
Idiopathic Pericarditis-an Autoinflammatory Disease?Norbert Blank, Hanns-Martin Lorenz
Innere Medizin (Heidelberg, Germany)|July 26, 2023
[Drug therapy of rheumatoid arthritis: where do biologics and novel synthetic disease-modifying antirheumatic drugs stand today?]Dorothee Kaudewitz, Hanns-Martin Lorenz
Arthritis Research|July 12, 2002
Perspectives for TNF-alpha-targeting therapiesHanns-Martin Lorenz, Joachim R Kalden
Deutsche Medizinische Wochenschrift (1946)|July 13, 2021
[Ocular manifestations of Rheumatic diseases]Janine Günther, Regina Max, Hanns-Martin Lorenz
Zeitschrift Fur Rheumatologie|September 1, 2021
[Chronic inflammatory demyelinating polyneuropathy as differential diagnosis to polymyalgia rheumatica]Martin Schiller, Hanns-Martin Lorenz, Wolfgang Kick
Arthritis Research & Therapy|September 16, 2016
Rituximab induces phenotypical and functional changes of NK cells in a non-malignant experimental settingWolfgang Merkt, Hanns-Martin Lorenz, Carsten Watzl
Biochemical Pharmacology|October 14, 2003
The putative role of apoptosis-modified histones for the induction of autoimmunity in Systemic Lupus ErythematosusChristoph Gabler, Joachim R Kalden, Hanns-Martin Lorenz
European Journal of Rheumatology|December 4, 2018
IL1-blocking therapy in colchicine-resistant familial Mediterranean feverBirgit Maria Köhler, Hanns-Martin Lorenz, Norbert Blank
Pageof 18